Latest debt-to-equity ratio

First Tracks Biotherapeutics Debt-to-equity ratio

Direct answer

First Tracks Biotherapeutics's debt-to-equity ratio is 2.57%.

The verified market snapshot reports 2.57%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 23, 2026.

Get free First Tracks Biotherapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Debt-to-equity ratio
2.57%